RETROLEAD Trademark

Trademark Overview


On Monday, October 26, 2020, a trademark application was filed for RETROLEAD with the United States Patent and Trademark Office. The USPTO has given the RETROLEAD trademark a serial number of 90278106. The federal status of this trademark filing is REGISTERED as of Tuesday, November 9, 2021. This trademark is owned by Ruilidi (Shanghai) Biopharma Co., Ltd.. The RETROLEAD trademark is filed in the Pharmaceutical Products category with the following description:

Injectable pharmaceuticals preparations for the prevention and treatment of viral and infectious diseases, for the treatment of cancer; Injectable pharmaceuticals preparations for the prevention and treatment of bacteria-based diseases; Injectable pharmaceuticals preparations for the prevention and treatment of HIV/AIDS and hepatitis; Injectable pharmaceuticals preparations for the prevention and treatment of anaphylactic reactions; Medicinal preparations for the mouth to be applied in the form of capsules; Medicinal preparations for the mouth to be applied in the form of tablets; Biological preparations for the prevention and treatment of viral and infectious diseases, for the treatment of cancer; Biological preparations for the prevention and treatment of HIV/AIDS, hepatitis and liver diseases; Biological preparations for the prevention and treatment of respiratory system diseases; Pharmaceutical preparations for the prevention and treatment of HIV/AIDS; Pharmaceutical preparations f...
retrolead

General Information


Serial Number90278106
Word MarkRETROLEAD
Filing DateMonday, October 26, 2020
Status700 - REGISTERED
Status DateTuesday, November 9, 2021
Registration Number6551233
Registration DateTuesday, November 9, 2021
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, August 24, 2021

Trademark Statements


Description of MarkThe mark consists of the words "RETROLEAD" in stylized letters.
Goods and ServicesInjectable pharmaceuticals preparations for the prevention and treatment of viral and infectious diseases, for the treatment of cancer; Injectable pharmaceuticals preparations for the prevention and treatment of bacteria-based diseases; Injectable pharmaceuticals preparations for the prevention and treatment of HIV/AIDS and hepatitis; Injectable pharmaceuticals preparations for the prevention and treatment of anaphylactic reactions; Medicinal preparations for the mouth to be applied in the form of capsules; Medicinal preparations for the mouth to be applied in the form of tablets; Biological preparations for the prevention and treatment of viral and infectious diseases, for the treatment of cancer; Biological preparations for the prevention and treatment of HIV/AIDS, hepatitis and liver diseases; Biological preparations for the prevention and treatment of respiratory system diseases; Pharmaceutical preparations for the prevention and treatment of HIV/AIDS; Pharmaceutical preparations for the prevention and treatment of liver diseases; Pharmaceutical preparations for the prevention and treatment of respiratory syncytial virus; Pharmaceutical preparations for the prevention and treatment of respiratory system disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases, diabetes, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; Pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; Pharmaceutical preparations and substances for the prevention and treatment of viral and infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Medicines for antiviral purposes; Medicinal preparations for infective disorders; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the prevention and treatment of viral and infectious diseases; Dietetic foods adapted for medical use; Dietetic beverages adapted for medical use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, December 15, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameRuilidi (Shanghai) Biopharma Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressShanghai 200235
CN

Party NameRuilidi (Shanghai) Biopharma Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressShanghai 200235
CN

Party NameRuilidi (Shanghai) Biopharma Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressShanghai 200235
CN

Trademark Events


Event DateEvent Description
Tuesday, November 9, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, August 24, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 24, 2021PUBLISHED FOR OPPOSITION
Wednesday, August 4, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, July 19, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, July 15, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 15, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 12, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, April 3, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, April 3, 2021NON-FINAL ACTION E-MAILED
Saturday, April 3, 2021NON-FINAL ACTION WRITTEN
Friday, March 26, 2021ASSIGNED TO EXAMINER
Friday, March 12, 2021PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Monday, March 8, 2021ASSIGNED TO LIE
Tuesday, December 15, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, December 4, 2020TEAS VOLUNTARY AMENDMENT RECEIVED
Thursday, October 29, 2020NEW APPLICATION ENTERED IN TRAM